Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
Cosmos Health's Capital Expenditure for the
three
months ended in Sep. 2023 was $-2.15 Mil. Its Revenue for the
three
months ended in Sep. 2023 was $12.82 Mil.
Hence, Cosmos Health's Capex-to-Revenue for the
three
months ended in Sep. 2023 was 0.17.
Cosmos Health Capex-to-Revenue Historical Data
The historical data trend for Cosmos Health's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cosmos Health's Capex-to-Revenue
For the Medical Distribution subindustry, Cosmos Health's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health's Capex-to-Revenue Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Capex-to-Revenue falls into.
Cosmos Health Capex-to-Revenue Calculation
Cosmos Health's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (NAS:COSM) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Cosmos Health Capex-to-Revenue Related Terms
Thank you for viewing the detailed overview of Cosmos Health's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Cosmos Health (Cosmos Health) Business Description
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COSM has been successfully added to your 